RA-SE GENETICS financials
A multi-period view of the public annual-account figures reported for RA-SE GENETICS, with comparable measures and links to available source documents.
Company overviewRegistry number
0479179703
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for RA-SE GENETICS
2025 versus 2024
- Operating line
- €364,994
- EBITDA
- €170,472
- Total assets
- €1,035,806
- Equity
- -€940,212
-1%
+8.8%
+18.3%
+2.2%
EBITDA margin +46.7% · Equity ratio -90.8%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.